58
1 www.otoihealth.com One to One Interactive, 2010. All rights reserved. Beyond the Voice of the Customer: Neuromarketing Insights into Patient Engagement with Pharmaceutical Brand Web Sites April 8, 2010 One to One Interactive, 2010. All rights reserved.

OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

Embed Size (px)

DESCRIPTION

One to One Health and OTOinsights will share the results of a first-of-its-kind pharma neuromarketing study which moves user effectiveness research beyond the focus group or the and inevitable cognitive bias that results. The study, conducted using our proprietary Quantemo™ offering, examined not only how patients view but also neurologically react to and emotionally respond to pharmaceutical brand websites in a single therapeutic category (allergies). We will discuss the neurological, emotional, and eye tracking data collected and the implications that the results have on best practices for designing branded pharmaceutical websites.

Citation preview

Page 1: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

1www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Beyond the Voice of the Customer: Neuromarketing Insights into Patient Engagement with Pharmaceutical Brand Web Sites

April 8, 2010

One to One Interactive, 2010. All rights reserved.

Page 2: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

2www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Please Tweet About This Webinar!

@OnetoOneHealth@OTOinsights

#neuromarketing#allergymarketing#ePharma#ehealth

Page 3: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

3www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 4: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

4www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Agenda

Page 5: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

5www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Presenting Today

Seth Levine, Vice President/Director – One to One Health@silevine

Dan Berlin, Sr. Researcher – OTOinsights, a One to One Interactive company@banderlin

Jeremi Karnell, Co-founder & President – One to One Interactive@jkarnell

Page 6: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

6www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 7: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

7www.otoihealth.com One to One Interactive, 2010. All rights reserved.

One to One Health is a specialized practice group within One to One Interactive dedicated to delivering innovative, transformational healthcare and life sciences marketing strategies, programs and creative. Building on a broad base of category experience (including pharmaceuticals, devices, health information and healthcare delivery) combined with deep interactive channel, digital media, CRM, and social media marketing experience, we help clients chart the right path for them in what we call the “Digital Health Information Ecosystem™.”

RadiologyCritical CareHIVTransplantEndocrinology

Sampling of Therapy and Focus Areas:

RespiratoryDigestivePainDiabetesMen’s Health

Psychiatric/Mood DisordersNeurological/CNSSTDsCardiovascularWoman’s Health

DiagnosticsHealthcare DeliveryHealth InformationHealth Field Sales SupportPharmacy

Sampling of Clients:

Offering Solutions for:

HospitalsHealth NetworksDevice/DiagnosticsHealth InformationPharmacy RetailWidgets/Mobile

Pharmaceuticals/BiotechDTC – Branded, UnbrandedProfessional/HCP

Lead Generation/eCRM/emailMedia – Display, Search, SocialResearch Organizations & Foundations

7

About One to One Health

www.otoihealth.com

Page 8: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

8www.otoihealth.com One to One Interactive, 2010. All rights reserved.

OTOinsights | Amplifying Engagement

Brand Planning Information Design Neuromarketing Research

User Experience Research

• Eye-Tracking• Emotional Response• Neurological

Engagement

• Usability Testing• Focus Groups• In-Depth/Paired

Interviews• Online Surveys• Expert Evaluations• Accessibility Audits• Ethnographics

• Socially Informed/ Multi-Channel Personas• Engagement Mapping• Cultural Anthropology• Trend Spotting

• User Needs Analysis• Information Architecture• User Scenarios• Behavioral Use Cases• Feature Matrix• Wireframes• Site Maps• Prototype Development

Page 9: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

9www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 10: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

10www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Purpose of this Webinar

Provide you with the fundamentals of neuromarketing

Explain what “engagement” is and it’s relevance to the performance of digital media

Discuss how marketers can use neuromarketing studies to remove cognitive bias inherent in traditional testing

Discuss how neuromarketing studies can be used to effectively evaluate creative performance before it’s in-market

Share the results of a first-of-its kind neuromarketing study done in the pharmaceutical space

Page 11: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

11www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 12: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

12www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 13: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

13www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 14: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

14www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 15: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

15www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 16: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

16www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 17: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

17www.otoihealth.com One to One Interactive, 2010. All rights reserved.fMR

I

Page 18: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

18www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 19: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

19www.otoihealth.com One to One Interactive, 2010. All rights reserved.EEG

Page 20: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

20www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 21: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

21www.otoihealth.com One to One Interactive, 2010. All rights reserved.Bio

-Feed

back

Page 22: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

22www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 23: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

23www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 24: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

24www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 25: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

25www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 26: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

26www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 27: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

27www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Quantemo Engagement Index (QEI) combines data from traditional user research, information processing models, and socio-cultural models to correlate people’s felt experience of their emotions when interacting with media stimuli with their behavioral/physiological responses.

Quantemo™ Engagement Index (QEI)

Σ = Quantemo Behavioral Index + Quantemo Neurological Index + Emotional Tagging + Likert Rating

Page 28: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

28www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 29: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

29www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 30: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

30www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Overview of StudyIn this study, we compared participants’ levels of engagement with 8 static web pages from branded allergy medication web sites – both OTC and prescription brands

• Static web pages displayed in a random order• After all stimuli were shown, participants fill out emotional and rating surveys• Qualitative interview conducted• Participants were male and female, ages 25-55, current allergy suffers

Page 31: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

31www.otoihealth.com One to One Interactive, 2010. All rights reserved.

OVERALL ENGAGEMENT

Page 32: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

32www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Overall Engagement

Zyrtec

Claritin

Benedryl

Astepro

Xyzal

Astelin

Veramyst

Nasonex

-0.50

0.00

0.50

1.00

1.50

2.00

2.50

3.00

2.49

2.14

1.22

0.400.21

-0.05 -0.07-0.18

Quantemo Engagement Index

Site

QEI

• Multiple Calls to Action and navigations • Pleasing colors• OTC Status• Outdoor activity

• Page is mostly ISI• Single, lengthy

navigation• Single type of Call to

Action

Page 33: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

33www.otoihealth.com One to One Interactive, 2010. All rights reserved.

The Elements of Engagement

Zyrtec Xyzal Nasonex Astepro Benedryl Claritin Astelin Veramyst0.00

0.20

0.40

0.60

0.80

1.00

1.20

1.40 1.33 1.33

1.12

0.730.67

0.59

0.230.15

Quantemo Neurological Index

Site

QN

I

Actionable insights gained by triangulating on the consumer experience

Xyzal had high neurological engagement, but low overall engagement

Page 34: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

34www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Insight: The Elements of High & Low Engagement

High Engagement

OTC status People + Product Images ISI Toward Bottom Less Text Social Content Prominent Indication Prominent Messaging Areas Simple Navigation Choices

Low Engagement

– Rx status– Product Images Only– ISI Centrally Located– More Text– Patient Stories– Indication Not Prominent– Compact Messaging Areas– Complex Navigation Choices

Page 35: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

35www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Insight: The Elements of High & Low Engagement

Over the counter pharmaceuticals have an advantage over prescription medications• Higher levels of overall engagement

Zyrtec Claritin Benedryl Astepro Xyzal Astelin Veramyst Nasonex-0.50

0.00

0.50

1.00

1.50

2.00

2.50

3.00

2.49

2.14

1.22

0.400.21

-0.05 -0.07-0.18

Quantemo Engagement Index

Site

QEI

Page 36: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

36www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Claritin and ZyrtecOver the counter pharmaceuticals have an advantage over prescription medications• Higher levels of overall engagement• Claritin and Zyrtec had almost no associated negative emotions

Page 37: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

37www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Insight: The Elements of High & Low EngagementConsumers had low neurological engagement with pages without a prominent human face• Consumers also expect to see an image of the product

Zyrtec Xyzal Nasonex Astepro Benedryl Claritin Astelin Veramyst0.00

0.20

0.40

0.60

0.80

1.00

1.20

1.40 1.33 1.33

1.12

0.730.67

0.59

0.230.15

Quantemo Neurological Index

Site

QN

I

Page 38: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

38www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Astelin and Veramyst

Consumers had low neurological engagement with pages without a prominent human face• Consumers also expect to see an image of the product

Fold

Fold

Page 39: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

39www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Insight: The Elements of High & Low Engagement

A prominently placed, lengthy ISI treatment can be detrimental to consumer engagement

FoldFold

Page 40: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

40www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Insight: The Elements of High & Low Engagement

A prominent, text-heavy ISI section can be detrimental to consumer engagement

FoldFold

Page 41: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

41www.otoihealth.com One to One Interactive, 2010. All rights reserved.

0s-5s 6s-15s 16s-30s 0s-5s 6s-15s 16s-30s 0s-5s 6s-15s 16s-30sST Excitement LT Excitement Engagement

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

Xyzal Neuro Traces over Time

Neurological Trace and Seconds

Perc

ent

Insight: The Elements of High & Low Engagement

A prominent, lengthy ISI treatment can be detrimental to consumer engagement

• For Xyzal, neurological excitement increases while users focus on Features and ISI• Time is split in the last 15 seconds between the bottom Feature and the ISI

16-30 seconds

Page 42: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

42www.otoihealth.com One to One Interactive, 2010. All rights reserved.

0s-5s 6s-15s 16s-30s 0s-5s 6s-15s 16s-30s 0s-5s 6s-15s 16s-30sST Excitement LT Excitement Engagement

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

Nasonex Neuro Traces over Time

Neurological Trace and Seconds

Perc

ent

Insight: The Elements of High & Low Engagement

• For Nasonex, neurological excitement decreases while users focus on the navigation and ISI• Time is split in the last 15 seconds between the bottom Feature and the ISI

16-30 seconds

A prominent, lengthy ISI treatment can be detrimental to consumer engagement

Page 43: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

43www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Insight Review: The Elements of High & Low Engagement

Over the counter pharmaceuticals have an advantage over prescription medications• Higher levels of overall engagement and Zyrtec’s high long-term excitement• Claritin and Zyrtec had almost no associated negative emotions

Consumers had low neurological engagement with pages without a prominent human face• Consumers also expect to see an image of the product

A prominent, text-heavy ISI section can be detrimental to consumer engagement

Page 44: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

44www.otoihealth.com One to One Interactive, 2010. All rights reserved.

FEMALE VS. MALE ENGAGEMENT

Page 45: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

45www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Female vs. Male Engagement

Xyzal had high neurological engagement, but low overall engagement

Zyrtec Xyzal Nasonex Astepro Benedryl Claritin Astelin Veramyst0.00

0.20

0.40

0.60

0.80

1.00

1.20

1.40 1.33 1.33

1.12

0.730.67

0.59

0.230.15

Quantemo Neurological Index

Site

QN

I

Page 46: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

46www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Female vs. Male Engagement

Astelin Astepro Benedryl Claritin Nasonex Veramyst Xyzal Zyrtec0.00

0.50

1.00

1.50

2.00

2.50

Quantemo Neurological Index by Sex

Site

QN

I

Male Female

Women viewing Xyzal had the highest neurological engagement of all stimuli

Females, 16-30 seconds

Page 47: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

47www.otoihealth.com One to One Interactive, 2010. All rights reserved.

EYE TRACKING MYTHBUSTERS:THE ALLERGY EDITION

Page 48: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

48www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Eye Tracking Mythbusters: The Allergy Edition

16-30 seconds0-5 seconds 6-15 seconds

16-30 seconds

0-5 seconds

6-15 seconds

Fold

Page 49: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

49www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Eye Tracking Mythbusters: The Allergy Edition

Myth 1: People don’t read headlines – BUSTED• They do - and users expect to quickly see the indication

Myth 2: People don’t read body copy – BUSTED• They do - and early on

Myth 3: People don’t look for nor do they read the ISI – BUSTED• They do read it… albeit later

Page 50: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

50www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Eye Tracking Mythbusters: The Allergy Edition

0-5 seconds

Myth 1: People don’t read headlines – BUSTED• They do - and users expect to quickly see the indication

Page 51: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

51www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Eye Tracking Mythbusters: The Allergy Edition

0-5 seconds 6-15 seconds

0-5 seconds 6-15 seconds

0-5 seconds 6-15 seconds

Myth 2: People don’t read body copy – BUSTED• They do - and early on

Page 52: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

52www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Eye Tracking Mythbusters: The Allergy Edition

Not on AOI

Brand Logo

Top Nav1

HCP

Headline

FaceCopy

Feature

1

Feature

2 ISI

CoLogo1

CoLogo2

Site M

ap

Save CTA

Top Nav2

0

0.1

0.2

0.3

0.4

0.5

0.6

Xyzal Fixations per Second over Time

Area of Interest

Fixa

tions

per

Sec

ond

Not on AOI

Brand Logo

Top Nav

Nav

Headline

Copy

Product

Video CTA

Dr. CTA

Save CTA ISI

Site M

ap

Co Logos

0

0.1

0.2

0.3

0.4

0.5

Veramyst Fixations per Second over Time

Area of Interest

Fixa

tions

per

Sec

ond

Not on AOI

Brand Logo

Nav

Product

Headline

Face

Save CTACTA ISI

Co Logo

Site M

ap0

0.1

0.2

0.3

0.4

0.5

Nasonex Fixations per Second over Time

Area of Interest

Fixa

tions

per

Sec

ond

Not on AOI

Brand Logo

HCP

Top Nav

Product

Headline

Copy

Feature

Save CTA

Use CTA

Dr. CTA ISI

Site M

ap

Co Logo

0

0.1

0.2

0.3

0.4

0.5

Astepro Fixations per Second over Time

Area of Interest

Fixa

tions

per

Sec

ond

Not on AOI

Brand Logo

Top Nav

Headline

Product

Feature

Social C

TAHCP

Use CTA

Save CTA

Co Logo ISI

Site M

ap0

0.1

0.2

0.3

0.4

0.5

Astelin Fixations per Second over Time

Area of Interest

Fixa

tions

per

Sec

ond

6s-15s 16s-30s0s-5s

Myth 3: People don’t look for nor do they read the ISI – BUSTED• They do read it… albeit later

Page 53: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

53www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Eye Tracking Mythbusters: The Allergy Edition

Fold

Myth 3: People don’t look for nor do they read the ISI – BUSTED• They do read it… albeit later

Page 54: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

54www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Wrap Up

Methodologies and approach can be applied to any health or business vertical

Quantemo can be a critical part of brand planning, product launch, creative development and asset optimization efforts

Testing can be done on websites, landing pages, registration forms/buy flows, digital media, video, animation, email, games, kiosks and more…

Call us for a complementary consultation. Let us propose a study design that addresses your business needs and answers your most challenging questions

Page 55: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

55www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Page 56: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

56www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Contact One to One Health & OTOinsights

Seth Levine – Vice President/Director One to One health

Email: [email protected]: +1-617-425-7319International: add 00 + 1Mobile: 617-331-0397Website: otoihealth.comBlog: RxforDigital.comTwitter: @otointeractive

David LaPlante – Sr. Vice President, Sales & Marketing

Email: [email protected]: +1-775-771-5404International: add 00 + 1Website: otoinsights.comBlog: otoinsights.comTwitter: @otoinsights

Page 57: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

57www.otoihealth.com One to One Interactive, 2010. All rights reserved.

Upcoming One to One Interactive Webinar

April 15, 201011am ET & 2 pm ET (US)

How To Design Mobile Applications and Widgets That Will Connect Meaningfully with Your Customers

Visit http://bit.ly/mobileux for more information.

Page 58: OTOinsights / One to One Health - Allergy Webinar - Apr 8 2010

58www.otoihealth.com One to One Interactive, 2010. All rights reserved.